The world first two cases of severe fever with thrombocytopenia syndrome: An epidemiological study in Nagasaki, Japan. Issue 7 (July 2016)

• Record Type: Journal Article
• Authors: Kurihara, Shintaro; Satoh, Akira; Yu, Fuxun; Hayasaka, Daisuke; Shimojima, Masayuki; Tashiro, Masato; Saijo, Tomomi; Takazono, Takahiro; Imamura, Yoshifumi; Miyazaki, Taiga; Tsukamoto, Misuzu; Yanagihara, Katsunori; Mukae, Hiroshi; Saijo, Masayuki; Morita, Kouichi; Kohno, Shigeru; Izumikawa, Koichi
• Is Part Of: Journal of infection and chemotherapy. Volume 22:Issue 7(2016:Jul.)
• Page Start: 461
• Page End: 465
• Publication Date: 2016-07
• Subjects: Severe fever with thrombocytopenia syndrome -- First cases -- Epidemiology -- Antibody; Chemotherapy -- Periodicals; Infection -- Periodicals; Communicable diseases -- Chemotherapy -- Periodicals; 615.5805
• DOI: 10.1016/j.jiac.2016.04.001
• Languages: English
• ISSNs: 1341-321X

Abstract

Abstract: Severe fever with thrombocytopenia syndrome (SFTS) caused by the SFTS virus (SFTSV), a novel phlebovirus belonging to the family Bunyaviridae, was reported in China for the first time in 2009. We observed two cases where the SFTSV was isolated for the first time in Nagasaki, Japan, in 2005. Two males in their 60s, a farmer and a hunter, respectively, living in Nagasaki developed SFTS during the same period. The patients developed similar clinical symptoms and signs, such as fever, loss of consciousness, and multiple organ dysfunction. The farmer died and the hunter survived. A retrospective diagnosis of SFTS was made in 2013, and genetic analysis revealed that the patients were infected with different SFTSV strains. Retrospective analysis of cytokine production in non-fatal case revealed interleukin (IL)-6, IL-8 and interferon-γ level of acute phase was low and could be potential prognostic factors. As there are no epidemiological studies of positive rate of SFTSV antibody in people living in endemic areas in Japan, a field study was performed. Volunteers at high risk for tick bites, such as hunters, farmers, and soldiers, were recruited in 6 regions, including the areas where the SFTS cases occurred. Three hundred and twenty six volunteers in Nagasaki prefecture were examined and none of these tested positive for the SFTSV antibody. Our data indicates that the risk for SFTSV infection is not high in Nagasaki prefecture. Further collection of blood samples from endemic areas is warranted for the prevention of SFTSV infection.